150 related articles for article (PubMed ID: 8601523)
1. p53 expression in gestational trophoblastic disease.
Lee YS
Int J Gynecol Pathol; 1995 Apr; 14(2):119-24. PubMed ID: 8601523
[TBL] [Abstract][Full Text] [Related]
2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
4. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in human gestational trophoblastic tumors.
Li F; Shao Z; Cang W; Qian N
Chin Med J (Engl); 1998 Apr; 111(4):379-80. PubMed ID: 10374410
[No Abstract] [Full Text] [Related]
6. Expression of HOX gene products in normal and abnormal trophoblastic tissue.
Amesse LS; Moulton R; Zhang YM; Pfaff-Amesse T
Gynecol Oncol; 2003 Sep; 90(3):512-8. PubMed ID: 13678718
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
[TBL] [Abstract][Full Text] [Related]
10. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.
Cheung AN; Shen DH; Khoo US; Wong LC; Ngan HY
J Clin Pathol; 1998 Feb; 51(2):159-62. PubMed ID: 9602692
[TBL] [Abstract][Full Text] [Related]
11. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole.
Qiao S; Nagasaka T; Harada T; Nakashima N
Placenta; 1998; 19(5-6):361-9. PubMed ID: 9699956
[TBL] [Abstract][Full Text] [Related]
12. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
13. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
14. C-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype.
Bauer M; Horn LC; Kowalzik J; Mair W; Czerwenka K
Gen Diagn Pathol; 1997 Nov; 143(2-3):185-90. PubMed ID: 9443575
[TBL] [Abstract][Full Text] [Related]
15. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
17. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression analysis of inhibin-alpha and -beta subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua.
Kommoss F; Schmidt D; Coerdt W; Olert J; Müntefering H
Int J Gynecol Pathol; 2001 Oct; 20(4):380-5. PubMed ID: 11603223
[TBL] [Abstract][Full Text] [Related]
20. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
Fülöp V; Végh G; Doszpod J
Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]